AstraZeneca PLC
Close on Oct 19, 2026Market cap $255.76BP/E 25.1Yield 1.91%
AstraZeneca Total cash, cash equivalents & current investments by Year
Total cash, cash equivalents & current investments ($M) ($M)
AstraZeneca Total cash, cash equivalents & current investments: $5,741M in FY2025, up 1.5% from a year earlier.
Where the FY2025 figure comes from
“|| Cash and investments | 5,741 | 5,654”
Source: Form 6-K FY2025Q4 Earnings Release ↗
Reported in Form 6-K / 20-F Net Debt Table.
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Total cash, cash equivalents & current investments ($M) ($M) | Year on year | Source |
|---|---|---|---|---|
| FY2025 | Dec 31, 2025 | 5,741 | +1.5% | Form 6-K FY2025Q4 Earnings Release ↗ |
| FY2024 | Dec 31, 2024 | 5,654 | -5.2% | Form 6-K FY2024Q4 Earnings Release ↗ |
| FY2023 | Dec 31, 2023 | 5,962 | -6.9% | Form 6-K FY2023Q4 Earnings Release ↗ |
| FY2022 | Dec 31, 2022 | 6,405 | +0.1% | Form 6-K FY2022Q4 Earnings Release ↗ |
| FY2021 | Dec 31, 2021 | 6,398 | -19.9% | Form 6-K FY2021Q4 Earnings Release ↗ |
| FY2020 | Dec 31, 2020 | 7,992 | – | Form 6-K FY2020Q4 Earnings Release ↗ |
Breakdown
What makes up total cash, cash equivalents & current investments
Cite this data
StockData. (2026). AstraZeneca Total cash, cash equivalents & current investments ($M), annual FY2020–FY2025 [Data set]. Compiled from AstraZeneca SEC filings and investor materials. https://stockdatahq.com/stocks/azn/kpis/nd-total-cash
See every metric in the AstraZeneca KPI table. Data updated Oct 28, 2026.